Thyroid News

Levothyroxine therapy may help decrease tumor growth for adults with papillary thyroid microcarcinoma who are undergoing active surveillance, according to a study published in Thyroid.

Adults diagnosed with Graves’ disease who received vitamin D supplementation had a similar remission rate as people who did not receive a supplement, according to a study published in Thyroid.

VRDN-001 demonstrated positive preliminary results in the treatment of chronic thyroid eye disease in an ongoing phase 1/2 clinical trial, according to a press release from Viridian Therapeutics.

Exposure to some types of endocrine-disrupting chemicals may lead to alterations in thyroid function for reproductive-aged women, according to a study published in Toxics.

Women with low-risk papillary thyroid cancer are more fearful of undergoing a thyroidectomy compared with men, according to findings from a single-center study published in JAMA Otolaryngology – Head & Neck Surgery.

Patients treated with levothroxine are more likely to experience a reduction in quadricep muscle mass, which may increase the risk for knee osteoarthritis, according to data published in Arthritis Research & Therapy.

CHICAGO — Using three different statistical models, researchers determined that exposure to individual and a combination of 20 dioxins negatively affects thyroid function, according to a presenter at ENDO 2023.

There have been several changes in the management of low-risk thyroid cancer in recent years, but researchers are still trying to answer what level of surveillance is appropriate for patients.

R. Scott Struthers, PhD, had a lab job synthesizing peptide hormones as a college freshman. That experience launched a career featuring discovery of novel agents for endocrine diseases, women’s health conditions and cancers.

Experts from across the field of endocrinology will converge on Chicago beginning Thursday for the 2023 Endocrine Society annual meeting.